ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 2, 2001, Pages 511-523

  Tribius, Silke ^a   Pidel, Ann ^b   Casper, Diana ^b  

^a Dept Radiat Oncol Montefiore M ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

ATM; GBM; Glioma; Radiation

Indexed keywords

CELL CULTURE; DNA; PROTEINS; RADIOTHERAPY; REGRESSION ANALYSIS; TISSUE; TUMORS;

RADIORESISTANCE;

ONCOLOGY;

ATM PROTEIN; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; REGRESSION ANALYSIS; TUMOR CELL LINE; WESTERN BLOTTING;

BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; GLIOBLASTOMA; HUMANS; MUTATION; PROTEIN-SERINE-THREONINE KINASES; RADIATION TOLERANCE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0035370172     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01489-4     Document Type: Article

References (88)

1. Kornblith PL, Walker MD, Cassady JR. Neurologic oncology. Philadelphia: JB Lippincott; 1987. p. 35-48.
2. Shapiro W.R., Green S.B., Burger P.C., et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. J Neurosurg. 71:1989;1-9.
3. Walker M.D., Green S.B., Byar D.P., et al. Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery. N Engl J Med. 303:1980;1323-1329.
4. Salcman M. Survival in glioblastoma Historical perspective . Neurosurgery. 7:1980;435-439.
5. Lang F.F., Miller D.C., Koslow M., et al. Pathways leading to glioblastoma multiforme A molecular analysis of genetic alterations in 65 astrocytic tumors . J Neurosurg. 81:1994;427-436.
6. Leon S.P., Ahu J., Black P.M. Genetic aberrations in human brain tumors. Neurosurgery. 34:1994;708-722.
7. Morita M., Rosenblum M.K., Bilsky M.H., et al. Long-term survivors of glioblastoma multiforme clinical and molecular characteristics . J Neurooncol. 27:1996;259-266.
8. Newcomb E.W., Madonia W.J., Pisharody S., et al. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol. 3:1993;229-235.
9. Easton D.F. Cancer risks in A-T heterozygotes. Int J Radiat Biol. 66:1994;S177-S182.
10. Sedgwick RP, Boder E. Ataxia-telangiectasia. In: De Jong JMBV, editor. Hereditary neuropathies and spinocerebellar atrophies. Amsterdam: Elsevier; 1991. p. 347-423.
11. Taylor A.M.R., Harnden D.G., Arlett C.F., et al. Ataxia telangiectasia A human mutation with abnormal radiation sensitivity . Nature. 258:1975;427-429.
12. Meyn M.S. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55:1995;5991-6001.
13. Shiloh Y. Ataxia-telangiectasia Closer to unraveling the mystery . Eur J Hum Genet. 3:1995;116-138.
14. Houldsworth J., Lavin M.F. Effect of ionizing radiation on DNA synthesis in ataxia-telangiectasia cells. Nucleic Acids Res. 8:1980;3709-3720.
15. Painter R.B., Young B.R. Radiosensitivity of ataxia-telangiectasia A new explanation . Proc Natl Acad Sci USA. 91:1980;12549-12553.
16. Blocher D., Sigut D., Hannan M.A. Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate γ-irradiation as assayed by pulsed field gel electrophoresis. Int J Radiat Biol. 60:1991;791-802.
17. 241Am α-particles or bleomycin. Int J Radiat Biol Relat Stud Phys Chem Med. 51:1987;209-218.
18. Banin S., Moyal L., Shieh S., et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 281:1998;1674-1677.
19. Canman C.E., Lim D.S., Cimprich K.A., et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1998;1677-1679.
20. Khanna K.K., Keating K.E., Kozlov S., et al. ATM associates with and phosphorylates p53 Mapping the region of interaction . Nat Genet. 20:1998;398-400.
21. Gosink E.C., Chong M.J., McKinnon P.J. Ataxia telangiectasia mutated deficiency affects astrocyte growth but not radiosensitivity. Cancer Res. 59:1999;5294-5298.
22. Herzog K.H., Chong M.J., Kapsetaki M., et al. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science. 280:1998;1089-1091.
23. Ko L.J., Prives C. p53 Puzzle and paradigm . Genes Devel. 10:1996;1054-1072.
24. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;3307-3312.
25. Westphal C.H., Hayes K.P., Canman C.E., et al. Loss of atm radiosensitizes multiple p53 null tissues. Cancer Res. 58:1998;5637-5639.
26. Raff M.C. Glial cell diversification in the rat optic nerve. Science. 303:1989;390-396.
27. Bignami E., Eng L.F., Dahl D., et al. Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res. 43:1972;429-435.
28. Gillaspy G.E., Miller R.H., Samols D., et al. Antigenic and differentiative heterogeneity among human glioblastomas. Cancer Lett. 68:1993;215-224.
29. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning, a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1980. p. 458-459.
30. Greenblatt M.S., Bennett W.P., Hollstein M., et al. Mutations in the p53 tumor supressor gene clues to cancer etiology and molecular pathogenesis . Cancer Res. 65:1994;4855-4878.
31. Sidransky D., von Eschenback A., Ysai Y.C., et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science. 252:1991;706-709.
32. Beroud C., Soussi T. p53 gene mutation Software and database . Nucleic Acids Res. 26:1998;200-204.
33. Waldman T., Zhang Y., Dillehay L., et al. Cell-cycle arrest versus cell death in cancer therapy. Nat Med. 3:1997;1034-1036.
34. Allalunis-Turner M.J., Barron G.M., Day R.S.I., et al. Radiosensitivity testing of human primary brain tumor specimens. Int J Radiat Oncol Radiat Oncol Phys. 23:1992;339-343.
35. Ramsay J., Ward R., Bleehen N.M. Radiosensitivity testing of human malignant gliomas. Int Radiat Oncol Biol Phys. 24:1992;675-680.
36. Taghian A., Suit H., Pardo F., et al. In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int. J Radiat Biol Phys. 23:1992;55-62.
37. Allam A., Taghian A., Gioioso D., et al. Intratumoral heterogeneity of malignant gliomas measured in vitro. Int J Radiat Oncol Biol Phys. 27:1993;303-308.
38. Taghian A., Ramsay J., Allalunis-Turner J., et al. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 25:1993;243-249.
39. Bigner D.D., Bigner S.H., Ponten J., et al. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropath Exp Neurol. 40:1981;201-229.
40. Gomez-Manzano C., Fueyo J., Kyritsis A.P., et al. Adenovirus-mediated transfer of the p53 gene produced rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 56:1996;694-699.
41. Bocchini V., Casalone R., Collini P., et al. Changes in gial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme. Cell Tissue Res. 265:1991;73-81.
42. Osborn M., Ludwig-Festl M., Weber K., et al. Expression of glial and vimentin type intermediate filaments in cultures derived from human glial material. Differentiation. 19:1981;161-167.
43. Yoshii Y., Maki Y., Tsuboi K., et al. Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors. J Neurosurg. 65:1986;659-663.
44. Chan DW, Gately DP, Urban S; et al. Lack of correlation between ATM protein expression and tumour cell radiosensitivity. Int J Radiat Biol 1998;74-217-224.
45. Lakin N.D., Weber P., Stankovic T., et al. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene. 13:1996;2707-2716.
46. Watters D., Khanna K.K., Beamish H., et al. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene. 14:1997;1911-1921.
47. Fukao T., Kaneko H., Birrell G., et al. ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells. Blood. 94:1999;1998-2006.
48. Gilad S., Chessa L., Khosravi R., et al. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet. 62:1998;551-561.
49. Gotoff S.P., Amirmokri E., Liebner E.J. Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis. Am J Dis Child. 114:1967;617-625.
50. Morgan JL, Holcomb TM, Morrissey RW. Radiation reaction in ataxia telangiectasia. Am J Dis Child 1968;116:557=-558.
51. Chen P.C., Lavin M.F., Kidson C., et al. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature. 274:1978;484-486.
52. o) T-lymphocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal doctors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes . Int J Radiat Biol. 54:1988;929-943.
53. Dahlberg W., Little J.B. Response of dermal fibroblast cultures from patients with unusually severe responses to radiotherapy and from ataxia-telangiectasia heterozygotes to fractional radiation. Clin Cancer Res. 1:1995;785-790.
54. Shiloh Y., Tabor E., Becker Y. The response of ataxia-telangiectasia homozygous skin fibroblasts to neocarzinostatin. Carcinogenesis. 3:1982;815-820.
55. Lavin M.F., Khanna K.K. Review ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia . Int J Radiat Biol. 75:1999;1201-1214.
56. Pandita T.K., Pathak S., Geard C.R. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet Cell Genet. 71:1995;86-93.
57. Foray N., Arlett C.F., Malaise E.P. Dose-rate effect on induction and repair rate of radiation-induced DNA double-strand breaks in a normal and an ataxia telangiectasia human fibroblast cell line. Biochimie. 77:1995;900-905.
58. Morgan S.E., Lovly C., Pandita T.K., et al. Fragments of ATM which have dominant-negative or complementing activity. Mol Cell Biol. 17:1997;2020-2029.
59. Zhang N., Chen P., Khanna K.K., et al. Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cell phenotype. Proc Natl Acad Sci USA. 94:1997;8021-8026.
60. Zhang N., Chen P., Gatei M., et al. An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells. Oncogene. 17:1998;811-818.
61. Barlow C., Ribaut-Barassin C., Zwingman T.A., et al. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc Natl Acad Sci USA. 97:2000;871-876.
62. Chong M.J., Murray M.R., Gosink E.C., et al. Atm and bax cooperate in ionizing radiation-induced apoptosis in the central nervous system. Proc Natl Acad Sci USA. 97:2000;889-894.
63. Guha C., Guha U., Tribius S., et al. Antisense ATM gene transfer A strategy to treat human glioblastoma . Gene Therapy. 7:2000;852-858.
64. Clarke A.R., Purdie C.A., Harrison D.J., et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;849-852.
65. Debbas M., White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:1993;546-554.
66. Lowe S.W., Ruley H.E., Jacks T., et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
67. Lowe S.W., Schmitt E.M., Smith S.W., et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
68. Yonish-Rouach E., Resnitzky D., Lotem J., et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 352:1991;345-347.
69. Kastan M.B., Zhan Q., El-Deiry W.S., et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
70. Khanna K.K., Lavin M.F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene. 8:1993;7491-7495.
71. Lu X., Lane D.P. Differential induction of transcriptionally active p53 following UV or ionizing radiation Defects in chromosome instability syndromes? Cell. 75:1993;765-778.
72. Xu Y., Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Devel. 10:1996;2401-2410.
73. Canman C.E., Wolff A.C., Chen C.-Y., et al. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54:1994;5054-5058.
74. Khanna K.K., Beamish H., Yan J., et al. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene. 11:1995;609-618.
75. Haas-Kogan D.A., Yount G., Haas M., et al. p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. Int J Radiat Oncol Biol Phys. 36:1996;95-103.
76. Haas-Kogan D.A., Dazin P., Hu L., et al. p53-independent apoptosis A mechanism of radiation-induced cell death of glioblastoma cells . Cancer J Sci Am. 2:1996;114-121.
77. Yount G.L., Haas-Kogan D.A., Vidair C.A., et al. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res. 56:1996;56:500-56:506.
78. Chozick B.S., Pezzullo J.C., Epstein M.H., et al. Prognostic implications of p53 overexpression in supratentorial astrocytic tumors. Neurosurgery. 35:1994;831-837.
79. Rasheed B.K., Mclendon R.E., Herndon J.E., et al. Alterations of the TP53 gene in human gliomas. Cancer Res. 54:1994;1324-1330.
80. Westphal C.H., Schmaltz C., Rowan S., et al. Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res. 57:1997;1664-1667.
81. Fisher D.E. Apoptosis in cancer therapy crossing the threshold . Cell. 78:1994;539-542.
82. BAX expression. Proc Natl Acad Sci USA. 95:1998;14453-14458.
83. Chen P., Iavarone A., Fick J., et al. Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet. 82:1995;106-115.
84. Ellison D.W., Gatter K.C., Steart P.V., et al. Expression of the p53 protein in a spectrum of astrocytic tumours. J Pathol. 168:1992;383-386.
85. Wu J.K., Ye Z., Darras B.T. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors. Neurosurgery. 33:1993;824-830.
86. Baskaran R., Wood L.D., Whitaker L.L., et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 387:1997;516-519.
87. Cortez D., Want Y., Qin J., et al. Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science. 286:1999;1162-1166.
88. Tibbetts R.S., Brumbaugh K.M., Williams J.M., et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Devel. 13:1999;152-157.